Find and compare companies providing Drug Substance (CDMO/CRO) services for:
Fine Chemicals
Filters
Production region
Production scale
Qualifications
CDMO-CRO
Plants in:
Established in: 1886
Production scale:
medium
small
Employees: 275+

Raw materials, CMO and OTC products

Two GMP certified locations

Customisable (small-sized) packages
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2013
Production scale:
medium
Employees: 25+

ISO9001 certified

Drug R&D center (in Hangzhou)

From lab scale (mg/g) to commercial scale (kgs/tons)
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2022
Production scale:
large
Employees: 50

Complex Chemistry Expertise – 30+ advanced chemistries backed by a strong R&D team

End-to-End Molecule Development from Idea to Commercial Scale

Global Quality, India Advantage – cGMP/FDA-compliant facilities, world-class SHE & IP standard at effecient pricing
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1964
Production scale:
small
medium
large
Employees: 135+

Market leader in Switzerland

Small and medium batch sizes

Pharmaceutical raw materials with a herbal or synthetic basis
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1987
Production scale:
medium
small
large
Employees: 50+

ISO 9001:2015 & SGS audited supplier

One-stop CDMO Solutions for APl and Key intermediates

Specialized in APIs & Pharmaceutical Intermediates for 38 years
All certificates
Replies quickly
Plants in:
Established in: 2014
Production scale:
small
medium
large
Employees: 1000+

24 years of production experience

6 workshops and 9 production lines which has 100t/month production capacity

4 USDMFS & 8 CEPS & 200+ Patents
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1951
Production scale:
medium
Employees: 455+

Largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market.

FDA approved european manufcaturing facilities

Export APIs to more than 60 countries worldwide
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1997
Production scale:
small
medium
Employees: 140

Top-tier adherence to global pharmaceutical standards including GMP, FDA and EMA

Specialized advanced chemistry laboratory focused on upscaling and GMP transfer processes

Comprehensive analytical services to meet precise client specifications.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1952
Production scale:
small
medium
large
Employees: 550+

API manufacturing (Innovators, Generics and Highly Potent)

A tailor-made and flexible service approach

State-of-the-art analytical services including solid form and QbD laboratories
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+

6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO

R&D Centers with capabilities of ANDAs, DMFs and NDDS

462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
Looking for Drug Substance (CDMO/CRO) Services?
Find a list of providers specializing in CMOs/CDMOs Services for Fine Chemicals. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
Drug Substance (CDMO/CRO)
Drug Substance CDMOs and CROs provide end-to-end solutions for pharmaceutical companies developing and manufacturing active pharmaceutical ingredients (APIs). These organizations offer critical support in R&D, process development, scale-up, and GMP manufacturing, enabling pharma and biotech companies to accelerate time-to-market while ensuring compliance with global regulatory standards.
Fine Chemicals
<
Fine chemicals outsourcing focuses on custom synthesis of high-purity chemical compounds used in drug substance supply chains.
A pharmaceutical CDMO develops and scales multi-step reactions, then manufactures material that meets tight purity specifications.
Typical steps include route development, hazard assessment, scale-up, and analytical method validation.
Key constraints often involve reaction complexity, impurity control, and campaign scheduling.
Practical answers for buyers sourcing CDMO services for fine chemical manufacturing.
A fine chemicals CDMO provides custom synthesis and manufacturing for complex chemical intermediates and APIs.
Services include process development, scale-up, and GMP manufacturing when required.
Fine chemicals often involve specialized, high-purity custom synthesis with flexible batch sizes.
API manufacturing focuses on a specific final drug substance step with defined regulatory requirements.
Include target compound, route summary, batch size, and purity specifications.
Add hazard information, solvent restrictions, and target markets if GMP is required.
Yes, many support multi-step synthesis and campaign manufacturing.
Confirm capability with similar reactions and scale ranges.
Scale can range from kilograms to multi-ton campaigns.
Provide demand forecasts and flexibility needs to match capacity planning.
Quality control uses analytical testing such as HPLC, GC, and spectroscopy to verify identity and purity.
Confirm in-house analytical capabilities and release timelines.
Some fine chemical CDMOs provide GMP manufacturing, while others focus on non-GMP.
Clarify GMP expectations and documentation needs early.
Ask about reactor capabilities, hazardous chemistry controls, and containment.
Safety reviews and solvent handling procedures are critical for complex reactions.
Pitfalls include unclear specifications, unexpected impurity profiles, and insufficient capacity planning.
Early alignment on quality targets and timelines reduces risk.
Yes, many provide tech transfer with process documentation and scale-up support.
Provide lab data and critical parameters to improve success.
Timelines depend on route maturity and reaction complexity.
New synthetic routes generally require additional development cycles.
Some CDMOs handle controlled substances under appropriate licenses.
Confirm regulatory approvals and secure handling procedures.
Documentation requirements depend on whether the output is an API or intermediate.
Confirm batch records, analytical data packages, and traceability expectations.
Filter by region, services, and scale, then compare chemistry experience and quality systems.
Shortlist partners with proven campaign manufacturing capability.
What is fine chemicals outsourcing (CDMO)?
When to choose a CDMO for fine chemicals
Common buyer requirements
Fine chemicals CDMO services FAQ
What does a fine chemicals CDMO provide for drug substance?
How are fine chemicals different from standard API manufacturing?
What should I include in a fine chemicals CDMO RFQ?
Do fine chemicals CDMOs support multi-step synthesis?
What scale ranges are typical for fine chemicals CDMO services?
How do fine chemicals CDMOs manage quality control?
Can fine chemicals CDMO services include GMP production?
How do I evaluate safety handling for fine chemicals?
What are common pitfalls in fine chemicals CDMO outsourcing?
Do fine chemicals CDMOs support tech transfer?
How long does fine chemical process development take?
Do fine chemicals CDMOs handle controlled substances?
What regulatory documentation is typical for fine chemical outsourcing?
How do I shortlist fine chemicals CDMO companies in this directory?











